CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jounce Therapeutics, Inc., a company focused on the discovery and development of novel cancer immunotherapies coupled to patient selection strategies, today announced that Richard Murray, Ph.D., chief executive officer, will present a company overview at the Leerink Partners Immuno-Oncology Roundtable on Thursday, October 1, 2015, at 1:30 p.m. ET. The conference is being held at the Le Parker Meridien Hotel in New York City.
Help employers find you! Check out all the jobs and post your resume.
